Alex Oshmyansky on Mark Cuban's Cost Plus Drugs and Healthcare Transparency

The Mission of Cost Plus Drugs

• 💊 Cost Plus Drugs aims to make medications affordable by operating with radical transparency.
• 💡 The company reveals its purchase price for drugs, adding a 15% markup, a $5 pharmacist fee, and $5 shipping and handling.
• 🎯 This model dramatically reduces costs for consumers, especially for expensive generic specialty medications, which can be found for $20-$30 instead of $2,000-$3,000.

The Problem with Healthcare Transparency

• ⚠️ The current healthcare system operates with fake list prices and hidden real prices, enabling numerous middlemen to profit from arbitrage.
• 💰 At least a third of US healthcare expenses are attributed to these middleman expenses.
• ✨ Transparency, or "sunlight as the best disinfectant," is key to dismantling this system by revealing actual costs.

Genesis of Cost Plus Drugs

• 🩺 Dr. Alex Oshmyansky, a radiologist, was motivated by patients dying due to unaffordable medications, like a generic drug costing $10,000/month.
• 💡 The idea evolved from a naive nonprofit concept to a for-profit public benefit corporation after struggling to find funding.
• 📧 A spontaneous email to Mark Cuban led to his investment and eventual co-founding of the company.

The Mark Cuban Partnership

• 🤝 Mark Cuban is a true co-founder, deeply involved in the day-to-day operations, surprising Oshmyansky with his granular attention to detail.
• 🚀 Cuban lending his name to the company was a significant signal of his commitment and helped overcome initial challenges in convincing pharmaceutical companies to partner.
• 📈 Despite Mark Cuban's name providing significant earned media, the company's growth is primarily driven by word-of-mouth on social media as satisfied customers share their savings.

The PBM Scam and Healthcare Costs

• 🚫 The high cost of prescription drugs in America is described as a "scam" driven by convoluted systems involving subsidiary companies, virtual manufacturers, and rebate aggregators.
• 📉 Pharmacy Benefit Managers (PBMs) emerged in the late 70s/early 80s, initially to process pharmacy reimbursements, but evolved to negotiate rebates, leading to inflated drug prices.
• 📈 PBMs incentivize high initial prices to maximize their percentage of rebates, resulting in discounts of up to 87% on generics, effectively doubling drug costs.
• 🚗 An analogy describes PBMs as "professional negotiators" who create a massive markup by setting an artificially high sticker price (e.g., $1 million for a Camry) and then offering a large discount, leaving consumers paying far more than the actual value.

Fixing the System and Future Outlook

• 🔑 Transparency is the foundational solution, enabling true negotiation and cost reduction.
• 🌐 Cost Plus Drugs works with transparent PBMs that charge flat fees per transaction instead of rebate percentages.
• 💰 Large employers can save millions by switching from the dominant PBMs to transparent models, as the PBMs' margins are essentially a tax on other industries.
• 🏥 The company aims to grow its four branches: manufacturing, wholesale marketplace, direct-to-consumer pharmacy, and employee benefits, to provide affordable medication access to anyone in need.
• 💬 Testimonials highlight significant monthly savings for individuals and families, validating the company's mission to help real people.